Literature DB >> 18343770

[Epidemiology, risk factors and molecular pathogenesis of primary liver cancer].

Krisztina Hagymási1, Zsolt Tulassay.   

Abstract

Primary liver cancer is the fifth most common cancer worldwide. Hepatocellular carcinoma accounts for 85-90% of primary liver cancers. Distribution of hepatocellular carcinoma shows variations among geographic regions and ethnic groups. Males have higher liver cancer rates than females. Hepatocellular carcinoma occurs within an established background of chronic liver disease and cirrhosis (70-90%). Major causes (80%) of hepatocellular carcinoma are hepatitis B, C virus infection, and aflatoxin exposition. Its development is a multistep process. We have a growing understanding on the molecular pathogenesis. Genetic and epigenetic changes activate oncogenes, inhibit tumorsuppressor genes, which result in autonomous cell proliferation. The chromosomal instability caused by telomere dysfunction, the growth-retrained environment and the alterations of the micro- and macroenvironment help the expansion of the malignant cells. Understanding the molecular mechanisms could improve the screening of patients with chronic liver disease, or cirrhosis, and the prevention as well as treatment of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343770     DOI: 10.1556/OH.2008.28313

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  9 in total

1.  Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population.

Authors:  Juan Zhou; Ruixue Lv; Xingbo Song; Dongdong Li; Xin Hu; Binwu Ying; Yonggang Wei; Lanlan Wang
Journal:  DNA Cell Biol       Date:  2011-08-23       Impact factor: 3.311

2.  Original Research: Analysis of hepatic microRNA alterations in response to hepatitis B virus infection and pegylated interferon alpha-2a treatment.

Authors:  Thananya Jinato; Natthaya Chuaypen; Witthaya Poomipak; Kesmanee Praianantathavorn; Jarika Makkoch; Rattanaporn Kiatbumrung; Kanisa Jampoka; Pisit Tangkijvanich; Sunchai Payungporn
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

3.  Liver Yin deficiency tonifying herbal extract induces apoptosis and cell senescence in Bel-7402 human hepatocarcinoma cells.

Authors:  Bing Hu; Hong-Mei An; Ke-Ping Shen; Ling Xu; Qin DU; Shan Deng; Yang Wu
Journal:  Exp Ther Med       Date:  2011-10-12       Impact factor: 2.447

4.  The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population.

Authors:  Miao Hu; Lianying Zhao; Surong Hu; Jingting Yang
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

5.  Association between two common polymorphisms and risk of hepatocellular carcinoma: evidence from an updated meta-analysis.

Authors:  Zhaoming Wang; Lei Zhang; Xuesong Shi; Huayu Xu; Ting Wang; Jianmin Bian
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

6.  High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.

Authors:  Xiao-Yan Duan; Qin Pan; Shi-Yan Yan; Wen-Jin Ding; Jian-Gao Fan; Liang Qiao
Journal:  BMC Gastroenterol       Date:  2014-11-20       Impact factor: 3.067

7.  Impact of contrast ultrasound diagnosis for patients with liver cancer.

Authors:  Hong-Bin Guo; Jun-Hu Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

8.  CXCR4 promotes gefitinib resistance of Huh7 cells by activating the c-Met signaling pathway.

Authors:  Dali Zhao; Zhiqiang Yang; Chen Chen; Zhipeng Zhang; Yangsheng Yu; Zhituo Li
Journal:  FEBS Open Bio       Date:  2021-10-19       Impact factor: 2.693

9.  Oxidored-nitro domain-containing protein 1 expression is associated with the progression of hepatocellular carcinoma.

Authors:  Deng-Qing Li; Ming Qiu; Xin-Min Nie; Rong Gui; Min-Zhu Huang
Journal:  Oncol Lett       Date:  2016-03-22       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.